Recent Headlines
Within Pharmaceuticals
GENINVO Introduces CodeMagic: AI‑Assisted Code Generation for Statistical Programming
GENINVO, a leading provider of transformative digital solutions for the life sciences sector, proudly announces the launch of CodeMagic, an innovative AI‑assisted coding platform designed to accelerate and simplify statistical programming across clinical research and pharmaceutical... - April 05, 2026 - GenInvo, Inc.
Brain Healing, Inc. Receives FDA Humanitarian Use Device (HUD) Designation for MELAS
Non-invasive biophoton platform advances toward HDE pathway for rare mitochondrial disease - April 01, 2026 - Tesla BioHealing, Inc.
PRISM ALS: New Stem Cell Models Could Transform Research Into Treatments for MND/ALS
PRISM ALS is a new global initiative designed to accelerate the discovery of effective treatments for ALS/MND by improving access to specially grown, patient-derived stem cell models that better reflect the biological diversity of the disease. - March 31, 2026 - ALS Therapy Development Institute
Best Joint Supplement: Movanze™ Wins Award
Best joint supplement is the title Movanze™ has now been awarded in Norway for 2026, after being recognized with the distinction “Best Joint Support Supplement of the Year, Norway 2026” in the Logistics & Supply Chain Awards, conducted by Global Brands Magazine. - March 31, 2026 - Nordics Co AS
AkrivisBio Inc., a New and Original Manufacturer of Metabolic Assay Kits
AkrivisBio is a provider of assay kits for the life science and biotechnology industries. AkrivisBio products include a variety of chemical, biochemical and enzyme activity assays as well as cell proliferation and toxicity assays, sample isolation and preparation kits, and staining kts. The kits... - March 29, 2026 - AkrivisBio
SignaBlok Receives Orphan Drug Designation from FDA for a First-in-Class TREM-1 Peptide Inhibitor for the Treatment of Retinopathy of Prematurity
SignaBlok, Inc., a preclinical stage biotechnology company pioneering novel, first-in-class peptide therapies for multiple inflammation-associated diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the Company’s TREM-1 peptide... - March 27, 2026 - SignaBlok, Inc.
SignaBlok to Present Novel Approach to Preventing Cancer Recurrence at the 2026 American Association for Cancer Research (AACR) Annual Meeting
• In experimental pancreatic cancer, macrophage-targeted but not cell-unspecific TREM-1 inhibitor: 1) prevents cancer recurrence, improves complete response rate and survival, when administered in a time window of 7 days after standard-of-care (SOC) chemotherapy, and 2) reverses immunosuppression and overcomes cancer resistance to anti-PD-L1 immunotherapy - March 26, 2026 - SignaBlok, Inc.
Size Stream Achieves SOC 2 - Type 2 Compliance, Reinforcing Commitment to Enterprise-Grade Security and Data Privacy
Size Stream announced successful completion of its SOC 2 Type 2 audit, validating the security, privacy, and reliability of its AI-powered body scanning platform. The certification confirms rigorous controls protecting sensitive body and biometric data used across health, fitness, and apparel applications—including made-to-measure, size recommendations, and clothing configurators—giving clients confidence to deploy body data solutions at scale. - March 18, 2026 - Size Stream
Longevity Rx Partners with Equinox Hotels to Bring Clinical-Grade Cellular Health Supplements to Luxury Hospitality
Dr. Will Cole's functional medicine-backed supplement brand joins Equinox Hotels' curated high-performance offering at the flagship Hudson Yards location. - March 17, 2026 - Longevity Rx
Industry Legend Bodybuilding.com Launches Bodybuilding Health Plus, Expanding into Personalized Metabolic, Wellness, and Quality-of-Life Support
Bodybuilding.com, a trusted leader in fitness and performance for over two decades, today announced the launch of Bodybuilding Health Plus, a new service designed to expand access to personalized health and wellness solutions. The platform introduces innovative offerings in metabolic health,... - March 16, 2026 - Bodybuilding.com
Bodybuilding.com Announces Bodybuilding Health Plus Partnership
Bodybuilding.com today announced its new health services partnership. The launch of Bodybuilding Health Plus will officially go live on March 16, marking a significant expansion into personalized metabolic, wellness, and sexual health support. Bodybuilding Health Plus broadens the company’s... - March 14, 2026 - Bodybuilding.com
Unpack Your Glow with Piece of Cake Moving & C.O. Bigelow
C.O. Bigelow and Piece of Cake Moving, two iconic brands, are partnering to launch the Moving Day Glow Up Kit, bringing a touch of luxury and thoughtful detail to the first night in your new home. C.O. Bigelow is America’s oldest apothecary, pairing nearly two centuries of time-honored... - March 12, 2026 - C.O. Bigelow
Listening to Spravato™ Publishes a New Standard for Music‑Assisted Support in Esketamine Treatment
Listening to Spravato™, a guide to music‑assisted support for esketamine treatment, is now available in print and digital formats. Written by jazz musician and technologist Justin Page, the book introduces a practical, safety‑forward framework for using music to enhance patient stability, emotional grounding, and therapeutic outcomes during Spravato® sessions. - March 12, 2026 - Justin Page
PDI Acquires Chemical Systems Services Inc. Assets; Expanding Industrial Scrubbing and Air Handling Capabilities
Plastics Design Industries (“PDI”), a provider of custom plastic fabrication and engineered solutions for cleanroom, chemical, and controlled-environment applications, announced today that it has completed the acquisition of select assets of Chemical Systems Services Inc. (“Chemical Systems”) in an asset purchase transaction. - March 11, 2026 - Plastic Design Industries
Hemanext ONE® Receives 510(k) Clearance for Expanded Indications for Use in the United States
Hemanext Inc. today announced that the Hemanext ONE® System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded indications for use in the United States. The expanded Indications for Use enable processing of whole blood and apheresis-derived AS-3 leukocyte-reduced red blood cells. - March 10, 2026 - Hemanext
Learn it Media Announces Acquisition of EvergreenCSD Division; Rose Janssen Joins as Vice President of Client Services
Learn it Media, a leading internal communications firm specializing in driving positive workforce performance, today announced the acquisition of EvergreenCSD’s Employee Engagement division — a move that expands the company’s capabilities, strengthens its leadership team, and... - March 05, 2026 - SEMM Holdings
POM Health Announces Agreement with GRAIL to Offer Its Galleri® MCED Test
POM Health Systems, a cancer screening service offering oncologist-led subscription cancer screening plans, today announced that it has reached an agreement with GRAIL, Inc., to offer its Galleri® multi-cancer early detection (MCED) test. Under the terms of the agreement, POM will deploy the... - March 05, 2026 - POM Health Systems
Liquet™ Medical Receives Second FDA 510(k) Clearance for Versus™ Catheter
Expands Hemodynamics-Led Thrombolysis (HLT) Platform and Unlocks New Interventional Segment. - March 05, 2026 - Liquet Medical Inc.
Komal Medical Launches Direct Dawai for Online Pharmacy in Jaipur
Komal Medical & Provision Store is a familiar and trusted name in Jaipur. The store has a strong presence in the city, not for now, but for many years. It is known for its reliable service and genuine medicine, with an aim for maximum client satisfaction. Daily, hundreds of people buy... - February 28, 2026 - Direct Dawai
Elait Health and Airmeez Announce Merger to Create Unified AI Platform for Healthcare Data and Intelligent Engagement
Elait Health a leader in AI-powered health data management, today announced that it has reached an agreement to merge with Airmeez Inc., a U.S. based company delivering AI-enhanced business interactions centered on intelligent voice and engagement solutions. The merger brings together two highly... - February 25, 2026 - Elait Health
Visu UDI Upgraded to Automate Regulatory Data Validation and Seamless EUDAMED Submissions
DDi launches Visu UDI for global UDI compliance—streamlining data validation, EUDAMED submissions, and master data management. With M2M connectivity and strict rules, it ensures accurate data across FDA, NMPA, and EU markets. - February 25, 2026 - DDi LLC
Shane Ray Appointed as President and Chief Executive Officer of Hemanext
Hemanext Inc., a leading innovator in blood processing, storage and transfusion technology, is pleased to announce that the Board has appointed Shane Ray to take on the role of President and Chief Executive Officer of Hemanext from Andy Dunham. Shane will also retain his role as the Chief Commercial Officer to lead the global commercial strategy and sales team while Andy will remain on the Executive Leadership Team as Hemanext’s Chief Scientific Officer. - February 24, 2026 - Hemanext
TKSoftware Launches AI-Powered ICONIC Pro Billing Software to Reduce Claim Denials and Maximize Reimbursements
TKSoftware Inc. today announced AI-Powered ICONIC Pro Billing Software. Designed to assist the office staff code charges correctly and efficiently. This is a major leap forward in Healthcare Billing Software powered by the best in class clearinghouse and revenue cycle support team in the industry. - February 13, 2026 - TKSoftware Inc.
Thar Process Unveils New Line of CO2 Bulk Delivery Systems for Any Prep SFC and Pilot Scale SFE Users
Thar has a 35-year history of building automated supercritical systems and operating R&D labs. For many years, Thar also built CO2 delivery systems to make it easier for any client to access CO2 without the inconvenience of CO2 bottles/tanks inside the lab. This automation provides a fast return on investment for company's trying to mitigate labor costs and safety risks. - February 13, 2026 - Thar Process
Malawian Physician Dr. Agnes Moses Wins $500,000 Gerson L’Chaim Prize to Expand Surgical Care and Strengthen Healthcare Systems at Partners in Hope Hospital
African Mission Healthcare announced Dr. Agnes Moses, Executive Director of Partners in Hope Hospital in Malawi, as the 2025 Gerson L’Chaim Prize recipient. The $500,000 award will expand surgical services through a new surgeon and laparoscopic equipment, supporting a proven system that cares for 220,000+ HIV patients and strengthens healthcare delivery across nine districts. - February 05, 2026 - African Mission Healthcare
Bio-Neuroscience 2026 Selects 12 Pioneering Companies to Present at Premier Global Neuroscience Drug Development Summit
Bio-Neuroscience today announced the selection of 12 neuroscience drug development companies to present at Bio-Neuroscience 2026, the premier global gathering of neuroscience innovation leaders, investors, and pharmaceutical executives. The companies were chosen from a competitive international field following rigorous evaluation of their scientific innovation, clinical progress, therapeutic approach, and commercial potential. - February 04, 2026 - Broadreach Global LLC
Curasia Medilabs Enters High-Growth Tamil Nadu Market with Monopoly PCD Pharma Franchise Model
Tamil Nadu is one of the most prospective pharmaceutical and healthcare markets in India. It has a highly developed healthcare system, increased medical knowledge, and a growing need for branded medicines of ethical origin. With its monopoly-based PCD franchise system in the state, Curasia Medilabs intends to establish a strong regional presence and provide partners with complete territorial exclusivity. - February 04, 2026 - Curasia Medilabs Pvt. Ltd.
Infinite Labs Solves Supplement Industry's Biggest Problem: Poor Absorption with Clinically-Proven Liposomal Technology
Infinite Labs launches clinically-proven liposomal supplement line with 10X better absorption than traditional supplements. Backed by six peer-reviewed studies, the technology achieves 67% faster cellular delivery and 90%+ encapsulation efficiency. Four formulas now available: Vitamin C+, Glutathione+, Magnesium+, and Vitamin D3 & K2+. - January 31, 2026 - Infinite Labs
I Holland Celebrates 80 Years of Excellence with a Global Series of Free Seminars
In 2026, I Holland proudly reaches an exciting milestone: 80 years of excellence in tablet compression tooling. Founded in 1946, I Holland has spent eight decades advancing tablet compression technology, sharing industry-leading expertise, and supporting customers around the world. To celebrate... - January 29, 2026 - I Holland Ltd.
CanVeer Biopharma Accepted Into Prestigious Intellectual Property Ontario (IPON) Program to Advance IP Strategy for Neonatal Therapy
CanVeer has been accepted into the highly competitive & prestigious Intellectual Property Ontario (IPON) Program. Through IPON CanVeer is eligible to receive up to CAD $300,000 in lifetime funding (on an 80% cost-share basis) to strengthen its intellectual property portfolio for its lead asset AlveoShield™. The program also grants access to expert advisory services in IP strategy, commercialization, training, and portfolio development. - January 28, 2026 - CanVeer Biopharma Inc.
Geoprise Founder’s Recent Book Dents Rampant AI Hype
Interest in artificial intelligence fell sharply after book was published two months ago. - January 22, 2026 - Geoprise Technologies Corporation
CalStop™ Named Weight-Loss Supplement of the Year
CalStop™ has been awarded “Weight-loss Supplement of the Year” at the Global Brands Magazine Awards 2025, reinforcing the product’s position as a science-aligned and quality-focused brand within the weight-management supplement category. - January 16, 2026 - Nordics Co AS
Qinecsa Signals Next Growth Chapter with Appointment of Alex Livingstone-Learmonth as Chief Commercial Officer
Alex will drive global commercial strategy and help scale Qinecsa’s next-generation pharmacovigilance technology across the life sciences ecosystem. - January 16, 2026 - Qinecsa Solutions
CanVeer Biopharma Launches Validation Program for Flagship Neonatal Therapeutic and Appoints Executive Team
CanVeer announces the launch of the validation program for its flagship product, AlveoShield™ (Investigational New Drug). The program targets preterm newborns with or at risk of developing bronchopulmonary dysplasia (BPD). Bronchopulmonary dysplasia is a chronic respiratory disease affecting preterm neonates who require assisted ventilation. AlveoShield™ is designed to potentially prevent and treat BPD. CanVeer also announces the appointment of Sherif Louis as CEO and Behzad Yeganeh as CSO. - January 13, 2026 - CanVeer Biopharma Inc.
Steadfast Partners Helps OP Consulting Group NW Achieve CMMC Level 1 Self-Attestation
Steadfast Partners, a leading cybersecurity consultancy, is proud to announce its successful collaboration with OP Consulting Group NW, enabling the organization to complete its Cybersecurity Maturity Model Certification (CMMC) Level 1 self-attestation. This achievement underscores both... - January 12, 2026 - Steadfast Partners LLC
Global Diabetes and Endocrinology Summit 2026 to Convene International Experts in a Live Virtual Webinar
The Global Diabetes and Endocrinology Summit is an international scientific forum dedicated to advancing research, education, and collaboration in diabetes and endocrinology. The summit brings together experts from academia, clinical practice, and research institutions to share insights that drive innovation and improve patient outcomes worldwide. - January 09, 2026 - The Global Diabetes and Endocrinology Summit
Pharmacy XD Launches Nationally Licensed Direct-to-Patient Mail Order Pharmacy and Distribution Platform - Headquartered in Florida’s Fastest-Growing Healthcare Corridor
Pharmacy XD LLC, a fully licensed Florida Department of Health–approved national mail order pharmacy and distribution facility, today officially announces its direct-to-patient (DTP) platform. Positioned in the heart of one of Florida’s most dynamic healthcare and life sciences... - January 08, 2026 - Pharmacy XD LLC
IGETHI Welcomes You to January
A New Kind of Reset for a New Kind of Consumer. January is more than just a month on the calendar. It's a mindset. - January 07, 2026 - IGETHI
Cumberland Biotherapeutics Announces U.S. Launch of FDA Cleared DentoClude F, Complimentary Practice Program, and New Investor Fundraising Initiative
Cumberland Biotherapeutics, LLC, a dental innovation company integrating advanced bioactive glass with botanicals, today announced the U.S. launch of DentoClude F; DentoClude F is marketed under a commercial name for the Occlude® F Dentin Tubule Agent, which received FDA 510(k) clearance under... - December 30, 2025 - Cumberland Biotherapeutics, Inc
Techead Successfully Completes CMMC Level 1 Self-Attestation with Steadfast Partners’ Support
Techead, a leading provider of creative and IT staffing solutions, proudly announces the successful completion of its Cybersecurity Maturity Model Certification (CMMC) Level 1 Self-Attestation, reinforcing its commitment to safeguarding sensitive information and supporting clients in the defense... - December 29, 2025 - Steadfast Partners LLC
Nudge Establishes Leadership in 10% Nano Hydroxyapatite Toothpaste with Advanced REMIN+ Enamel Formula
Nudge, an Orlando, Florida–based oral care brand, advances fluoride free enamel care with its Nano Hydroxyapatite REMIN+ toothpaste, formulated around a high concentration 10% nano hydroxyapatite framework. Built by oral care experts with a passion over profits mindset, Nudge focuses on science backed formulation, transparency, and long term oral health. - December 29, 2025 - Nudge
Biostem Pharma Private Limited Becomes a Preferred Partner for Third-Party Pharma Manufacturing in India
Biostem Pharma Private Limited strengthens its position as a preferred partner for third-party pharma manufacturing in India. The company offers WHO-GMP-compliant production of tablets, capsules, syrups, and topical formulations, catering to both startups and established pharma brands. - December 29, 2025 - Biostem Pharma Pvt Ltd
Elait Health Recognised in the 2025 Gartner® Market Guide for Health Data Management Platforms
Elait Health today announced it has been recognized as a Representative Vendor in the 2025 Gartner® Market Guide for Health Data Management Platforms (HDMP), authored by Gartner Analyst Laura Craft in July 2025. This recognition highlights Elait Health’s momentum as it enters its Series A... - December 28, 2025 - Elait Health
Curasia Medilabs Private Limited Offers Monopoly-Based PCD Pharma Franchise Opportunities
Curasia Medilabs Private Limited announces monopoly-based PCD pharma franchise opportunities, offering exclusive territories, a diversified product range, and structured partner support across India. - December 27, 2025 - Curasia Medilabs Pvt. Ltd.
AlloDx Unveils SuperNAT Platform: Breakthrough in Nephrin Antibody Detection for Podocyte Disease
The SuperNAT platform demonstrates 48.6% higher sensitivity than conventional ELISA, with its clinical validation data accepted for poster at ASN Kidney Week 2025. - December 25, 2025 - AlloDx
Orange Biotech Launches Innovative Third-Party Pharma Manufacturing Platform to Empower Indian Pharma Brands
Orange Biotech has launched an advanced Third-Party Pharma Manufacturing platform aimed at helping pharma companies, startups, and PCD franchise owners manufacture high-quality formulations efficiently. The platform offers WHO-GMP compliant production, customized product development, regulatory assistance, and pan-India distribution support, strengthening Orange Biotech’s position as a trusted B2B pharma solutions provider. - December 24, 2025 - Orange Biotech Pvt. Ltd.
Fleming Events Launches: Process Control Week: PID Tuning & Advanced Process Control Training, 9–13 March 2026, Amsterdam
Process Industries Face Rising Demand for Precision Control, Energy Efficiency, and Advanced Automation - December 19, 2025 - Fleming Events
Fleming Event Launches: In-Line Inspection and Inspection of Challenging Pipelines, 10–13 March 2026 in Amsterdam.
Pipeline Integrity Enters a New Risk Era - Inspection of Challenging Pipelines, 10–13 March 2026 in Amsterdam - December 19, 2025 - Fleming Events
Creative BioMart Enhances Host Cell Protein Mitigation Service to Strengthen Biotherapeutic Quality
Creative BioMart, a leading biotechnology company specializing in protein and biopharmaceutical solutions, has announced an enhancement to its host cell protein service. The upgraded offering introduces a more integrated and data-driven approach to identifying, quantifying, and reducing host cell... - December 11, 2025 - Creative BioMart
iFyber Expands Analytical Capabilities with Launch of Advanced LC-MS Services
iFyber has expanded its LC-MS analytical capabilities with advanced Orbitrap and UHPLC technology and the addition of industry experts Gary Schultz, PhD, and Brian Hoffman. The enhanced platform boosts sensitivity and analytical depth, supporting proteomics, metabolomics, E&L, and contaminant testing, strengthening iFyber’s mission to deliver high-quality, decision-driving preclinical insights. - December 10, 2025 - iFyber